Table 2 Management alternatives for treating idiopathic ovarian vein thrombosis
Management | Duration | Follow up for resolution |
|---|---|---|
Warfarin (INR 2–3) | 6 weeks to 6 months | USS or CT at 6 weeks to 6 months |
LMWH switched to apixaban | 6 months | Clinical review at 3 and 6 months |
LMWH switched to rivaroxaban | 3 months | CTAP at 2 months |
LMWH switched to warfarin (INR 2–3) | 6 months | Clinical review at 6 months |
UFH switched to warfarin | 1 to 2 months | USS or CT at 1 to 2 months |
Rivaroxaban | 8 months | USS at week 6 and 12 |
Apixaban | 3 months | Clinical review at 3 months |